Meeting
2015 ASCO Annual Meeting
Perioperative morbidity and mortality with bleomycin in primary mediastinal non seminomatous germ cell tumor (PMNSGCT).
Authors
Praveen Ranganath
Indiana University School of Medicine, Indianapolis, IN
Praveen Ranganath , Kenneth Kesler , John Dentel , Lawrence H. Einhorn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Germ Cell/Testicular
Citation
J Clin Oncol 33, 2015 (suppl; abstr 4538)
DOI
10.1200/jco.2015.33.15_suppl.4538
Abstract #
4538
Poster Bd #
211
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Prognostic significance of raised serum tumor markers (STM) after 2 cycles of chemotherapy in men with intermediate- and poor-risk non-seminomatous testicular germ cell tumors (NSGCT) treated at a single-centre in India.
First Author: ANKUR NANDAN VARSHNEY
Poster
2020 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Shalini Subramaniam
Poster
2019 ASCO Annual Meeting
Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT).
First Author: Darren R. Feldman
Poster
2019 Genitourinary Cancers Symposium
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs).
First Author: Alison Yan Zhang